Drug
9-aminocamptothecin clinical trials
Also written aminocamptothecin.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 1995
How studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
6 studies that test it; most in 1995 (4)
| Year | Studies |
|---|---|
| 1995 | 4 |
| 1996 | 1 |
| 1998 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
National Cancer Institute (NCI) (2) · University of Chicago (1) · Yale University (1) · NYU Langone Health (1) · Dana-Farber Cancer Institute (1)
Studies
Open first, then newest update. How each study uses 9-aminocamptothecin is read from its arms, and is right about nine times in ten.
Testing it · 6
- Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the EsophagusCompletedPhase 2University of ChicagoNCT00003192Written as aminocamptothecin
- Aminocamptothecin in Treating Patients With T-cell LymphomaCompletedPhase 2Yale UniversityNCT00002635Written as aminocamptothecin
- Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedPhase 2National Cancer Institute (NCI)NCT00002745Written as aminocamptothecin
- Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian CancerCompletedPhase 2NYU Langone HealthNCT00002671Written as aminocamptothecin
- Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory LeukemiaCompletedPhase 1Dana-Farber Cancer InstituteNCT00251368Written as 9-Aminocamptothecin (9-AC)
- A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and CisplatinCompletedPhase 2National Cancer Institute (NCI)NCT00001427Written as 9-aminocamptothecin
Codes
What other systems call 9-aminocamptothecin · ClinicalTrials.gg INT003715
- MeSH (NLM) C0801259-aminocamptothecinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5MB77ICE2Q9-AMINOCAMPTOTHECINConfirmed FDA, NLM, Wikidata
- Wikidata Q271498089-aminocamptothecinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1488AminocamptothecinOne source FDA
- DrugBank DB12515One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C080125 | 9-aminocamptothecin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5MB77ICE2Q | 9-AMINOCAMPTOTHECIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27149808 | 9-aminocamptothecin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1488 | Aminocamptothecin | One source FDA |
| DrugBank | DB12515 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.